相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Disruption of MEF2C signaling and loss of sarcomeric and mitochondrial integrity in cancer-induced skeletal muscle wasting
Angie M. Y. Shum et al.
AGING-US (2012)
Metabolic Modeling of Dynamic Brain 13C NMR Multiplet Data: Concepts and Simulations with a Two-Compartment Neuronal-Glial Model
Alexander A. Shestov et al.
NEUROCHEMICAL RESEARCH (2012)
Animal models of the cancer anorexia-cachexia syndrome
Nabila Bennani-Baiti et al.
SUPPORTIVE CARE IN CANCER (2011)
Phase II nonrandomized study of the efficacy and safety of COX-2 inhibitor celecoxib on patients with cancer cachexia
Giovanni Mantovani et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2010)
Marine phospholipids-a promising new dietary approach to tumor-associated weight loss
Lenka A. Taylor et al.
SUPPORTIVE CARE IN CANCER (2010)
Cancer cachexia: medical management
Giovanni Mantovani et al.
SUPPORTIVE CARE IN CANCER (2010)
Effect of adenosine 5′-triphosphate infusions on the nutritional status and survival of preterminal cancer patients
Sandra Beijer et al.
ANTI-CANCER DRUGS (2009)
Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice
K. van Norren et al.
BRITISH JOURNAL OF CANCER (2009)
Attenuation of proteolysis and muscle wasting by curcumin c3 complex in MAC16 colon tumour-bearing mice
Rafat A. Siddiqui et al.
BRITISH JOURNAL OF NUTRITION (2009)
Attenuation of skeletal muscle atrophy in cancer cachexia by d-myo-inositol 1,2,6-triphosphate
S. T. Russell et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Therapeutic potential of interleukin-15: a myokine involved in muscle wasting and adiposity
Josep M. Argiles et al.
DRUG DISCOVERY TODAY (2009)
Update on emerging drugs for cancer cachexia
Kate T. Murphy et al.
EXPERT OPINION ON EMERGING DRUGS (2009)
L-Glutamine Use in the Treatment and Prevention of Mucositis and Cachexia: A Naturopathic Perspective
Jody E. Noe
INTEGRATIVE CANCER THERAPIES (2009)
Microarray analysis suggests that burn injury results in mitochondial dysfunction in human skeletal muscle
A. Aria Tzika et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2009)
Curcumin and muscle wasting-A new role for an old drug?
Nima Alamdari et al.
NUTRITION (2009)
Orally Available Selective Melanocortin-4 Receptor Antagonists Stimulate Food Intake and Reduce Cancer-Induced Cachexia in Mice
Philipp Weyermann et al.
PLOS ONE (2009)
Inhibition of Atrogin-1/MAFbx Mediated MyoD Proteolysis Prevents Skeletal Muscle Atrophy In Vivo
Julie Lagirand-Cantaloube et al.
PLOS ONE (2009)
An update on promising agents for the treatment of cancer cachexia
Clelia Madeddu et al.
Current Opinion in Supportive and Palliative Care (2009)
Cachexia: A new definition
William J. Evans et al.
CLINICAL NUTRITION (2008)
PGC-1 coactivators and skeletal muscle adaptations in health and disease
Zolt Arany
CURRENT OPINION IN GENETICS & DEVELOPMENT (2008)
Giant mitochondria do not fuse and exchange their contents with normal mitochondria
Marian Nauratil et al.
EXPERIMENTAL CELL RESEARCH (2008)
Apoptosis signalling is essential and precedes protein degradation in wasting skeletal muscle during catabolic conditions
Josep A. Argiles et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Effects of CRF2R agonist on tumor growth and cachexia in mice implanted with lewis lung carcinoma cells
Josep M. Argiles et al.
MUSCLE & NERVE (2008)
Cyclooxygenase-2 inhibitors and antioxidants in the treatment of cachexia
Giovanni Mantovani et al.
Current Opinion in Supportive and Palliative Care (2008)
Prevention of upper aerodigestive tract cancer in zinc-deficient rodents: Inefficacy of genetic or pharmacological disruption of COX-2
Louise Y. Y. Fong et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
FoxO3 coordinately activates protein degradation by the Autophagic/Lysosomal and proteasomal pathways in atrophying muscle cells
Jinghui Zhao et al.
CELL METABOLISM (2007)
Emerging drugs for cancer cachexia
Josep M. Argiles et al.
EXPERT OPINION ON EMERGING DRUGS (2007)
Antiproteolytic effects of plasma from hibernating bears:: A new approach for muscle wasting therapy
Gernma Fuster et al.
CLINICAL NUTRITION (2007)
Apoptosis is present in skeletal muscle of cachectic gastro-intestinal cancer patients
Silvia Busquets et al.
CLINICAL NUTRITION (2007)
Are peroxisome proliferator-activated receptors involved in skeletal muscle wasting during experimental cancer cachexia?: Role of β2-adrenergic agonists
Gemma Fuster et al.
CANCER RESEARCH (2007)
Cancer cachexia signaling pathways continue to emerge yet much still points to the proteasome
Swarnali Acharyya et al.
CLINICAL CANCER RESEARCH (2007)
A new general-purpose fully automatic baseline-correction procedure for 1D and 2D NMR data
J. Carlos Cobas et al.
JOURNAL OF MAGNETIC RESONANCE (2006)
PGC-1α a protects skeletal muscle from atrophy by suppressing Fox03 action and atrophy-specific gene transcription
Marco Sandri et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The molecular mechanisms of skeletal muscle wasting: Implications for therapy
R. J. E. Skipworth et al.
SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND (2006)
Local and distant burn injury alter immuno-inflammatory gene expression in skeletal muscle
Katie E. Padfield et al.
JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE (2006)
Mitochondrial and nuclear DNA-repair capacity of various brain regions in mouse is altered in an age-dependent manner
Syed Z. Imam et al.
NEUROBIOLOGY OF AGING (2006)
Complementary action of the PGC-1 coactivators in mitochondrial biogenesis and brown fat differentiation
Marc Uldry et al.
CELL METABOLISM (2006)
Mass-dependent decline of skeletal muscle function in cancer cachexia
M Gorselink et al.
MUSCLE & NERVE (2006)
Dystrophin glycoprotein complex dysfunction: A regulatory link between muscular dystrophy and cancer cachexia
S Acharyya et al.
CANCER CELL (2005)
The pivotal role of cytokines in muscle wasting during cancer
JM Argilés et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Proton NMR spectroscopy shows lipids accumulate in skeletal muscle in response to burn trauma-induced apoptosis
LG Astrakas et al.
FASEB JOURNAL (2005)
Molecular mechanisms involved in muscle wasting in cancer and ageing:: cachexia versus sarcopenia
JM Argilés et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2005)
Burn injury causes mitochondrial dysfunction in skeletal muscle
KE Padfield et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial
JN Gordon et al.
GUT (2005)
Both oxidative and nitrosative stress are associated with muscle wasting in tumour-bearing rats
E Barreiro et al.
FEBS LETTERS (2005)
TNF-α acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle
YP Li et al.
FASEB JOURNAL (2005)
Activation of UCPs gene expression in skeletal muscle can be independent on both circulating fatty acids and food intake involvement of ROS in a model of mouse cancer cachexia
S Busquets et al.
FEBS LETTERS (2005)
Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy
M Sandri et al.
CELL (2004)
The pharmacological treatment of cachexia
JM Argilés et al.
CURRENT DRUG TARGETS (2004)
Anticachectic effects of formoterol:: A drug for potential treatment of muscle wasting
S Busquets et al.
CANCER RESEARCH (2004)
Cancer cachexia is regulated by selective targeting of skeletal muscle gene products
S Acharyya et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
Mechanism of the attenuation of proteolysis-inducing factor stimulated protein degradation in muscle by β-hydroxy-β-methylbutyrate
HJ Smith et al.
CANCER RESEARCH (2004)
Signaling pathways weigh in on decisions to make or break skeletal muscle
DC Guttridge
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE (2004)
Ghrelin increases energy intake in cancer patients with impaired appetite: Acute, randomized, placebo-controlled trial
NM Neary et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Multiple types of skeletal muscle atrophy involve a common program of changes in gene expression
SH Lecker et al.
FASEB JOURNAL (2004)
Mechanisms underlying cancer-induced symptoms
HB Gutstein
DRUGS OF TODAY (2003)
Increase in signal-to-noise ratio of >10,000 times in liquid-state NMR
JH Ardenkjaer-Larsen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Skeletal muscle metabolism in physiology and in cancer disease
A Giordano et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Bioenergetic analysis of peroxisome proliferator-activated receptor γ coactivators 1α and 1β (PGC-1α and PGC-1β) in muscle cells
J St-Pierre et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Altered expression of skeletal muscle myosin isoforms in cancer cachexia
GM Diffee et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2002)
The role of uncoupling proteins in pathophysiological states
JM Argilés et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
Wnt signaling promotes oncogenic transformation by inhibiting c-Myc-induced apoptosis
ZB You et al.
JOURNAL OF CELL BIOLOGY (2002)
Muscle UCP-3 mRNA levels are elevated in weight loss associated with gastrointestinal adenocarcinoma in humans
P Collins et al.
BRITISH JOURNAL OF CANCER (2002)
Molecular regulation of muscle cachexia: It may be more than the proteasome
PO Hasselgren et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2002)
In vivo effects of uncoupling protein-3 gene disruption on mitochondrial energy metabolism
GW Cline et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Wnt-1 signaling inhibits apoptosis by activating β-catenin/T cell factor-mediated transcription
SQ Chen et al.
JOURNAL OF CELL BIOLOGY (2001)
Muscle cachexia: Current concepts of intracellular mechanisms and molecular regulation
PO Hasselgren et al.
ANNALS OF SURGERY (2001)
13C/31P NMR assessment of mitochondrial energy coupling in skeletal muscle of awake fed and fasted rats -: Relationship with uncoupling protein 3 expression
BM Jucker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
NF-κB-induced loss of MyoD messenger RNA:: Possible role in muscle decay and cachexia
DC Guttridge et al.
SCIENCE (2000)
Assessment of mitochondrial energy coupling in vivo by 13C/31P NMR
BM Jucker et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
DNA fragmentation occurs in skeletal muscle during tumor growth:: A link with cancer cachexia?
M van Royen et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2000)
Selective activation of NF-κB subunits in human breast cancer:: potential roles for NF-κB2/p52 and for Bcl-3
PC Cogswell et al.
ONCOGENE (2000)
分享论文
